MetLife Investment Management’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6M Sell
33,682
-768
-2% -$56K 0.01% 995
2026
Q1
$2.25M Sell
34,450
-893
-3% -$66.3K 0.01% 1001
2025
Q4
$2.8M Sell
35,343
-1,226
-3% -$93.9K 0.01% 905
2025
Q3
$2.67M Buy
36,569
+1,298
+4% +$95.1K 0.01% 946
2025
Q2
$2.67M Sell
35,271
-628
-2% -$44.5K 0.02% 854
2025
Q1
$2.73M Sell
35,899
-684
-2% -$50.9K 0.01% 895
2024
Q4
$2.42M Buy
36,583
+652
+2% +$45.6K 0.01% 944
2024
Q3
$2.51M Sell
35,931
-927
-3% -$55.8K 0.01% 908
2024
Q2
$1.95M Buy
+36,858
New +$2.24M 0.01% 984

Other funds holding SOLV

MetLife Investment Management's SOLV Position: Q2 2026 in Review

MetLife Investment Management reduced its Solventum (SOLV) stake by 2.2% in Q2 2026, selling an estimated $56K and leaving 33,682 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #995.

MetLife Investment Management first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.8M in Q4 2025. 886 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • MetLife Investment Management held 33,682 shares of Solventum worth $2.6M as of Q2 2026.
  • MetLife Investment Management sold 768 Solventum shares in Q2 2026, an estimated $56K.
  • Solventum made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #995 holding.
  • MetLife Investment Management first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • MetLife Investment Management's Solventum position peaked at $2.8M in Q4 2025.
  • 886 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.